Patient Portal

Kenneth R. Carson, MD

Assistant Professor, Medicine
Division of Oncology

Specialty Areas

Medical Oncology
Lymphoma
Leukemia
Internal Medicine

Hospital Affiliations

Barnes-Jewish Hospital

Areas of Clinical Interest

Lymphoma, multiple myeloma, oncology, cancer, leukemia

  • Location(s)
  • Education
  • Publication & Research
  • Financial Disclosures

Location(s)

Location(s)

Center for Advanced Medicine

4921 Parkview Place
St. Louis, MO 63110

Suite: B
Floor: 7
Office Phone: 314-747-1171

Barnes-Jewish West County Hospital 
Siteman Cancer Center
Medical Building Two

10 Barnes West Drive
Creve Coeur, MO 63141
Phone: 314-747-7222

Office Phone: 314-747-1171

Education

Education

Fellowship: Hematology/Oncology, Northwestern University, McGaw Medical Center, Chicago, Illinois 2008
Medical Degree: University of Southern California, Keck School of Medicine, Los Angeles, California 2000
Residency: Duke University Medical Center, Durham, North Carolina 2003
Fellowship: Institute for Healthcare Studies, Northwestern University, Chicago, Illinois 2006
B.S.: University of Southern California, Los Angeles California 1995

Publication & Research

Publication & Research

CLINICAL AND GENOMIC CHARACTERISTICS OF SMALL CELL LUNG CANCER IN NEVER-SMOKERS: RESULTS FROM A RETROSPECTIVE MULTICENTER COHORT STUDY.
Thomas A, Mian I, Tlemsani C, Pongor L, Takahashi N, Maignan K, Snider J, Li G, Frampton G, Ali S, Kim S, Nichols S, Rajapakse V, Guha U, Sharon E, Fujimoto J, Moran CA, Wistuba II, Wei JS, Khan J, Szabo E, Torres AZ, Carson KR
Chest. 2020 May 25; pii: S0012-3692(20)31504-X. doi: 10.1016/j.chest.2020.04.068.

PMID:
    32464188
    [PubMed - as supplied by publisher]
Related citations


Reflections on and future of hematologic malignancies research in the Veterans Health Administration.
Friedman DR, Carson KR, Weinberg JB
Semin Oncol. 2019 Aug - Oct; 46(4-5)346-350. doi: 10.1053/j.seminoncol.2019.09.004.

PMID:
    31699443
    [PubMed - indexed for MEDLINE]
Related citations


Metformin Use and Pancreatic Cancer Survival among Non-Hispanic White and African American U.S. Veterans with Diabetes Mellitus.
Toriola AT, Luo S, Thomas TS, Drake BF, Chang SH, Sanfilippo KM, Carson KR
Cancer Epidemiol Biomarkers Prev. 2020 Jan; 29(1)169-175. doi: 10.1158/1055-9965.EPI-19-0781.

PMID:
    31685560
    [PubMed - in process]
Related citations


Advancing age and the risk of bleomycin pulmonary toxicity in a largely older cohort of patients with newly diagnosed Hodgkin Lymphoma.
Thomas TS, Luo S, Reagan PM, Keller JW, Sanfilippo KM, Carson KR
J Geriatr Oncol. 2020 Jan; 11(1)69-74. doi: 10.1016/j.jgo.2019.09.009.

PMID:
    31668826
    [PubMed - in process]
Related citations


Post-MGUS Diagnosis Serum Monoclonal-Protein Velocity and the Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma.
Chang SH, Gumbel J, Luo S, Thomas TS, Sanfilippo KM, Luo J, Colditz GA, Carson KR
Cancer Epidemiol Biomarkers Prev. 2019 Dec; 28(12)2055-2061. doi: 10.1158/1055-9965.EPI-19-0132.

PMID:
    31501149
    [PubMed - in process]
Related citations


Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE VTE score.
Sanfilippo KM, Luo S, Wang TF, Fiala M, Schoen M, Wildes TM, Mikhael J, Kuderer NM, Calverley DC, Keller J, Thomas T, Carson KR, Gage BF
Am J Hematol. 2019 Nov; 94(11)1176-1184. doi: 10.1002/ajh.25603.

PMID:
    31379000
    [PubMed - indexed for MEDLINE]
Related citations


Novel cell adhesion/migration pathways are predictive markers of HDAC inhibitor resistance in cutaneous T cell lymphoma.
Andrews JM, Schmidt JA, Carson KR, Musiek AC, Mehta-Shah N, Payton JE
EBioMedicine. 2019 Aug; 46170-183. doi: 10.1016/j.ebiom.2019.07.053.

PMID:
    31358475
    [PubMed - indexed for MEDLINE]
Related citations


Mogamulizumab-Associated Cutaneous Granulomatous Drug Eruption Mimicking Mycosis Fungoides but Possibly Indicating Durable Clinical Response.
Chen L, Carson KR, Staser KW, Mehta-Shah N, Schaffer A, Rosman IS, Musiek A
JAMA Dermatol. 2019 May 29; doi: 10.1001/jamadermatol.2019.0369.

PMID:
    31141114
    [PubMed - as supplied by publisher]
Related citations


The role of autologous stem cell transplantation in patients with nodal peripheral T-cell lymphomas in first complete remission: Report from COMPLETE, a prospective, multicenter cohort study.
Park SI, Horwitz SM, Foss FM, Pinter-Brown LC, Carson KR, Rosen ST, Pro B, Hsi ED, Federico M, Gisselbrecht C, Schwartz M, Bellm LA, Acosta M, Advani RH, Feldman T, Lechowicz MJ, Smith SM, Lansigan F, Tulpule A, Craig MD, Greer JP, Kahl BS, Leach JW, Morganstein N, Casulo C, Shustov AR, COMPLETE Investigators.
Cancer. 2019 May 1; 125(9)1507-1517. doi: 10.1002/cncr.31861.

PMID:
    30694529
    [PubMed - indexed for MEDLINE]
Related citations


Real-World Outcomes of Patients with Metastatic Non-Small Cell Lung Cancer Treated with Programmed Cell Death Protein 1 Inhibitors in the Year Following U.S. Regulatory Approval.
Khozin S, Carson KR, Zhi J, Tucker M, Lee SE, Light DE, Curtis MD, Bralic M, Kaganman I, Gossai A, Hofmeister P, Torres AZ, Miksad RA, Blumenthal GM, Pazdur R, Abernethy AP
Oncologist. 2019 May; 24(5)648-656. doi: 10.1634/theoncologist.2018-0307.

PMID:
    30591549
    [PubMed - indexed for MEDLINE]
Related citations


Disparities in the Use of Programmed Death 1 Immune Checkpoint Inhibitors.
O'Connor JM, Seidl-Rathkopf K, Torres AZ, You P, Carson KR, Ross JS, Gross CP
Oncologist. 2018 Nov; 23(11)1388-1390. doi: 10.1634/theoncologist.2017-0673.

PMID:
    30012876
    [PubMed - indexed for MEDLINE]
Related citations


Speed of Adoption of Immune Checkpoint Inhibitors of Programmed Cell Death 1 Protein and Comparison of Patient Ages in Clinical Practice vs Pivotal Clinical Trials.
O'Connor JM, Fessele KL, Steiner J, Seidl-Rathkopf K, Carson KR, Nussbaum NC, Yin ES, Adelson KB, Presley CJ, Chiang AC, Ross JS, Abernethy AP, Gross CP
JAMA Oncol. 2018 Aug 1; 4(8)e180798. doi: 10.1001/jamaoncol.2018.0798.

PMID:
    29800974
    [PubMed - indexed for MEDLINE]
Related citations


Leveraging real-world data to move toward more personalized fertility treatment.
Jungheim ES, Carson KR
Fertil Steril. 2018 Apr; 109(4)608-609. doi: 10.1016/j.fertnstert.2018.01.036.

PMID:
    29653708
    [PubMed - indexed for MEDLINE]
Related citations


Analysis of Peripheral T-cell Lymphoma Diagnostic Workup in the United States.
Hsi ED, Horwitz SM, Carson KR, Pinter-Brown LC, Rosen ST, Pro B, Federico M, Gisselbrecht C, Schwartz M, Bellm LA, Acosta M, Collie AM, Gruver AM, Grzywacz BJ, Turakhia S, Shustov AR, Advani RH, Feldman T, Lechowicz MJ, Smith SM, Lansigan F, Tulpule A, Craig MD, Greer JP, Kahl BS, Leach JW, Morganstein N, Casulo C, Park SI, Foss FM
Clin Lymphoma Myeloma Leuk. 2017 Apr; 17(4)193-200. doi: 10.1016/j.clml.2016.10.001.

PMID:
    28209473
    [PubMed - indexed for MEDLINE]
Related citations


Reply to S. Suissa et al.
Sanfilippo KM, Luo S, Gage BF, Carson KR
J Clin Oncol. 2017 Apr 20; 35(12)1378-1379. doi: 10.1200/JCO.2016.71.3958.

PMID:
    28165899
    [PubMed - indexed for MEDLINE]
Related citations


Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma.
Krysiak K, Gomez F, White BS, Matlock M, Miller CA, Trani L, Fronick CC, Fulton RS, Kreisel F, Cashen AF, Carson KR, Berrien-Elliott MM, Bartlett NL, Griffith M, Griffith OL, Fehniger TA
Blood. 2017 Jan 26; 129(4)473-483. doi: 10.1182/blood-2016-07-729954.

PMID:
    28064239
    [PubMed - indexed for MEDLINE]
Related citations


Obesity and the Transformation of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma: A Population-Based Cohort Study.
Chang SH, Luo S, Thomas TS, O'Brian KK, Colditz GA, Carlsson NP, Carson KR
J Natl Cancer Inst. 2017 May; 109(5)doi: 10.1093/jnci/djw264.

PMID:
    28040690
    [PubMed - indexed for MEDLINE]
Related citations


A prospective cohort study of patients with peripheral T-cell lymphoma in the United States.
Carson KR, Horwitz SM, Pinter-Brown LC, Rosen ST, Pro B, Hsi ED, Federico M, Gisselbrecht C, Schwartz M, Bellm LA, Acosta MA, Shustov AR, Advani RH, Feldman TA, Lechowicz MJ, Smith SM, Lansigan F, Tulpule A, Craig MD, Greer JP, Kahl BS, Leach JW, Morganstein N, Casulo C, Park SI, Foss FM
Cancer. 2017 Apr 1; 123(7)1174-1183. doi: 10.1002/cncr.30416.

PMID:
    27911989
    [PubMed - indexed for MEDLINE]
Related citations


Weight change trends and overall survival in United States veterans with follicular lymphoma treated with chemotherapy.
Xiao DY, Luo S, O'Brian K, Liu W, Carson KR
Leuk Lymphoma. 2017 Apr; 58(4)851-858. doi: 10.1080/10428194.2016.1217526.

PMID:
    27669828
    [PubMed - indexed for MEDLINE]
Related citations


Progressive multi-focal leucoencephalopathy among ibrutinib-treated persons with chronic lymphocytic leukaemia.
Bennett CL, Berger JR, Sartor O, Carson KR, Hrushesky WJ, Georgantopoulos P, Raisch DW, Norris LB, Armitage JO
Br J Haematol. 2018 Jan; 180(2)301-304. doi: 10.1111/bjh.14322.

PMID:
    27649938
    [PubMed - indexed for MEDLINE]
Related citations

Financial Disclosures

Financial Disclosures

Disclosure of Financial Interests with Industry

Washington University and its physicians and health professionals are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians and health professionals work collaboratively with pharmaceutical, medical device or other medical care related companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our physicians and health professionals have an ownership or potential ownership interest in a commercial company; and/or are paid by a commercial company to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians or health professionals must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this website, physicians and health professionals earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.

This physician reported the following financial interests during calendar year 2019:

Company Name: Flatiron Health

Royalties:

Equity: Yes

Consulting/Advisory Board:

Speaker Fees:

Reporting Date: May 01, 2020